-
Faced with an infection threat to immunocompromised patients and an absence of clear public health guidelines, some hospitals are furloughing health care workers who receive the new live attenuated influenza vaccine (LAIV), Hospital Infection Control has learned.
-
-
-
As community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) increases, we now find that the bug can cause further problems by joining its nosocomial cousins in the hospital The fear used to be that MRSA would leave the hospital, but it appears community strains can just as likely come in.
-
Copper-silver ionization in potable waters was found to be highly effective in reducing environmental Legionella colonization and preventing nosocomial Legionnaires disease over prolonged time periods.
-
With visions of overrun, bankrupt hospitals and workers dying or refusing to treat patients, a recent government-commissioned study of an epidemic of severe acute respiratory syndrome (SARS) in the United States had everything but a nightmarish cover painting by Hieronymus Bosch.
-
Influenza information from the Centers for Disease Control and Prevention (CDC) includes the following answers to common questions about the new live attenuated influenza vaccine (LAIV).
-
Andromed (Montreal, Quebec) said that it plans to divest its Androfact system in order to refocus its activities on its Androsonix technology platform while developing additional commercial partners for its Androscope family of products.
-
The UK Department of Health has unveiled a new framework directed toward helping improve services for those suffering from heart disease. A new toolkit, the National Workforce Competence Framework for Coronary Heart Disease, sets out the core skills needed by National Health Service (NHS) staff to deliver the best services for those with, or at risk of, coronary disease. The skills covered concentrate of the priority areas of prevention, heart failure and rehabilitation.
-
Advances in Cardiovascular Technology: Emerging Markets for the 21st Century, Vol. 2, the newest sourcebook from the publishers of Cardiovascular Device Update and The BBI Newsletter, has just been released.
